These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5317012)

  • 1. Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2-Aichi-2-68 vaccine.
    Knight V; Couch RB; Douglas RG; Tauraso NM
    Bull World Health Organ; 1971; 45(6):767-71. PubMed ID: 5317012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses.
    Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS
    Bull World Health Organ; 1969; 41(3):525-30. PubMed ID: 5309467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy.
    Schoenbaum SC; Mostow SR; Dowdle WR; Coleman MT; Kaye HS
    Bull World Health Organ; 1969; 41(3):531-5. PubMed ID: 5309468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of live and inactivated vaccines of Hong Kong influenza virus in an industrial community. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.
    Hobson D; Baker FA; Curry RL; Beare AS; Massey PM
    J Hyg (Lond); 1973 Dec; 71(4):641-7. PubMed ID: 4588772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dosage and route of inoculation upon antigenicity of inactivated influenza virus vaccine (Hong Kong strain) in man.
    Tauraso NM; Gleckman R; Pedreira FA; Sabbaj J; Yahwak R; Madoff MA
    Bull World Health Organ; 1969; 41(3):507-16. PubMed ID: 5309465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field trial with human and equine influenza vaccines in children: protection and antibody titres.
    Wesselius-de Casparis A; Masurel N; Kerrebijn KF
    Bull World Health Organ; 1972; 46(2):151-7. PubMed ID: 4555773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Freestone DS; Hamilton-Smith S; Schild GC; Buckland R; Chinn S; Tyrrell DA
    J Hyg (Lond); 1972 Sep; 70(3):531-43. PubMed ID: 4506997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemagglutination-inhibiting antibody response to and efficacy of inactivated Hong Kong influenza vaccine.
    Sonoguchi T
    Bull World Health Organ; 1969; 41(3):517-23. PubMed ID: 5309466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization antibody response to A2 Hong Kong influenza vaccine and its duration in school age children.
    Hosai H; Omura S; Maeda A; Kunita N
    Biken J; 1970 Dec; 13(4):277-87. PubMed ID: 5510350
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of monovalent Hong Kong influenza virus vaccine with vaccines containing only pre-1968 Asian strains in adult volunteers. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Hobson D; Baker FA; Chivers CP; Reed SE; Sharp D
    J Hyg (Lond); 1970 Sep; 68(3):369-78. PubMed ID: 4917915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hong Kong influenza in the Royal Air Force 1968-70.
    Miller DL; Reid D; Daimond JR; Pereira MS; Chakraverty P
    J Hyg (Lond); 1973 Sep; 71(3):535-47. PubMed ID: 4518353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial.
    Mulligan MJ; Bernstein DI; Winokur P; Rupp R; Anderson E; Rouphael N; Dickey M; Stapleton JT; Edupuganti S; Spearman P; Ince D; Noah DL; Hill H; Bellamy AR;
    JAMA; 2014 Oct; 312(14):1409-19. PubMed ID: 25291577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic.
    Monto AS; Davenport FM; Napier JA; Francis T
    Bull World Health Organ; 1969; 41(3):537-42. PubMed ID: 5309469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
    Belshe RB; Frey SE; Graham IL; Anderson EL; Jackson LA; Spearman P; Edupuganti S; Mulligan MJ; Rouphael N; Winokur P; Dolor RJ; Woods CW; Walter EB; Chen WH; Turley C; Edwards KM; Creech CB; Hill H; Bellamy AR;
    JAMA; 2014 Oct; 312(14):1420-8. PubMed ID: 25291578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients.
    Kositanont U; Wongsurakiat P; Pooruk P; Maranetra N; Puthavathana P
    Viral Immunol; 2010 Jun; 23(3):329-34. PubMed ID: 20565296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.
    Treanor JJ; Campbell JD; Zangwill KM; Rowe T; Wolff M
    N Engl J Med; 2006 Mar; 354(13):1343-51. PubMed ID: 16571878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.